Literature DB >> 29219051

Development and Uses of Offline and Web-Searchable Metabolism Databases - The Case of Benzo[a]pyrene.

Slobodan P Rendic1, Frederick P Guengerich2.   

Abstract

BACKGROUND: The present work describes development of offline and web-searchable metabolism databases for drugs, other chemicals, and physiological compounds using human and model species, prompted by the large amount of data published after year 1990. The intent was to provide a rapid and accurate approach to published data to be applied both in science and to assist therapy.
METHODS: Searches for the data were done using the Pub Med database, accessing the Medline database of references and abstracts. In addition, data presented at scientific conferences (e.g., ISSX conferences) are included covering the publishing period beginning with the year 1976.
RESULTS: Application of the data is illustrated by the properties of benzo[a]pyrene (B[a]P) and its metabolites. Analysis show higher activity of P450 1A1 for activation of the (-)- isomer of trans-B[a]P-7,8-diol, while P4501B1 exerts higher activity for the (+)- isomer. P450 1A2 showed equally low activity in the metabolic activation of both isomers.
CONCLUSION: The information collected in the databases is applicable in prediction of metabolic drug-drug and/or drug-chemical interactions in clinical and environmental studies. The data on the metabolism of searched compound (exemplified by benzo[a]pyrene and its metabolites) also indicate toxicological properties of the products of specific reactions. The offline and web-searchable databases had wide range of applications (e.g. computer assisted drug design and development, optimization of clinical therapy, toxicological applications) and adjustment in everyday life styles. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  CYP; P450; benzo[a]pyrene; endobiotics.; metabolic activation; metabolism databases; transporters; web-database; xenobiotics

Mesh:

Substances:

Year:  2018        PMID: 29219051      PMCID: PMC5886801          DOI: 10.2174/1389200219666171207123939

Source DB:  PubMed          Journal:  Curr Drug Metab        ISSN: 1389-2002            Impact factor:   3.731


  172 in total

Review 1.  Update information on human P450s.

Authors:  F Peter Guengerich
Journal:  Drug Metab Rev       Date:  2002 Feb-May       Impact factor: 4.518

Review 2.  Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes.

Authors:  F P Guengerich; T Shimada
Journal:  Chem Res Toxicol       Date:  1991 Jul-Aug       Impact factor: 3.739

3.  Formation of (R)-8-hydroxywarfarin in human liver microsomes. A new metabolic marker for the (S)-mephenytoin hydroxylase, P4502C19.

Authors:  L C Wienkers; C J Wurden; E Storch; K L Kunze; A E Rettie; W F Trager
Journal:  Drug Metab Dispos       Date:  1996-05       Impact factor: 3.922

Review 4.  Update information on drug metabolism systems--2009, part I.

Authors:  F Peter Guengerich; Slobodan Rendic
Journal:  Curr Drug Metab       Date:  2010-01       Impact factor: 3.731

Review 5.  Polycyclic aromatic hydrocarbons: from metabolism to lung cancer.

Authors:  Bhagavatula Moorthy; Chun Chu; Danielle J Carlin
Journal:  Toxicol Sci       Date:  2015-05       Impact factor: 4.849

Review 6.  Pharmacogenomics of MRP transporters (ABCC1-5) and BCRP (ABCG2).

Authors:  Ulrike Gradhand; Richard B Kim
Journal:  Drug Metab Rev       Date:  2008       Impact factor: 4.518

7.  Expression of mammalian glutathione S-transferase 5-5 in Salmonella typhimurium TA1535 leads to base-pair mutations upon exposure to dihalomethanes.

Authors:  R Thier; J B Taylor; S E Pemble; W G Humphreys; M Persmark; B Ketterer; F P Guengerich
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

8.  Correlation of human cytochrome P4502C substrate specificities with primary structure: warfarin as a probe.

Authors:  L S Kaminsky; S M de Morais; M B Faletto; D A Dunbar; J A Goldstein
Journal:  Mol Pharmacol       Date:  1993-02       Impact factor: 4.436

9.  Activation of procarcinogens by human cytochrome P450 enzymes expressed in Escherichia coli. Simplified bacterial systems for genotoxicity assays.

Authors:  T Shimada; E M Gillam; P Sandhu; Z Guo; R H Tukey; F P Guengerich
Journal:  Carcinogenesis       Date:  1994-11       Impact factor: 4.944

Review 10.  Summary of information on the effects of ionizing and non-ionizing radiation on cytochrome P450 and other drug metabolizing enzymes and transporters.

Authors:  Slobodan Rendic; F Peter Guengerich
Journal:  Curr Drug Metab       Date:  2012-07       Impact factor: 3.731

View more
  2 in total

Review 1.  Human Family 1-4 cytochrome P450 enzymes involved in the metabolic activation of xenobiotic and physiological chemicals: an update.

Authors:  Slobodan P Rendic; F Peter Guengerich
Journal:  Arch Toxicol       Date:  2021-01-18       Impact factor: 5.153

Review 2.  Molecular Mechanisms of Action of Selected Substances Involved in the Reduction of Benzo[a]pyrene-Induced Oxidative Stress.

Authors:  Bożena Bukowska; Piotr Duchnowicz
Journal:  Molecules       Date:  2022-02-18       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.